Education
About Us
Working with TipRanks
Follow Us
Iovance Biotherapeutics (DE:2LB)
:2LB
Iovance Biotherapeutics (2LB) Ownership Overview
9.64% Insiders
17.91% Mutual Funds
35.62% Other Institutional Investors
16.92% ETFs
19.91% Public Companies and Individual Investors
The ownership structure of Iovance Biotherapeutics (DE:2LB) stock is a mix of institutional, retail, and individual investors. Approximately 70.45% of the company’s stock is owned by Institutional Investors, 9.64% is owned by Insiders, and 19.91% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 14, 2024 | Ryan Maynard Director | xxxxxxxxxxxxx | $503000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $407000 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $621600 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $4170469 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $163630768 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 28,067,333 | Insider | 9.21% | 158,804,970 | |
| 26,119,362 | Institution | 8.57% | 147,783,350 | |
| 23,562,124 | Institution | 7.73% | 133,314,498 | |
| 22,112,266 | Institution | 7.26% | 125,111,201 | |
| 13,039,975 | Institution | 4.28% | 73,780,179 | |
| 6,527,613 | Institution | 2.14% | 36,933,234 | |
| 4,575,551 | Institution | 1.50% | 25,888,468 | |
| 2,940,670 | Institution | 0.96% | 16,638,311 | |
| 2,767,497 | Institution | 0.91% | 15,658,498 | |
| 2,269,363 | Institution | 0.74% | 12,840,056 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 23,562,124 | Institution | 7.73% | 133,314,498 | |
| 4,575,551 | Institution | 1.50% | 25,888,468 | |
| 2,940,670 | Institution | 0.96% | 16,638,311 | |
| 2,767,497 | Institution | 0.91% | 15,658,498 | |
| 2,269,363 | Institution | 0.74% | 12,840,056 | |
| 2,033,590 | Institution | 0.67% | 11,506,052 | |
| 1,760,752 | Institution | 0.58% | 9,962,335 | |
| 1,743,736 | Institution | 0.57% | 9,866,058 | |
| 1,445,665 | Institution | 0.47% | 8,179,573 | |
| 1,369,666 | Institution | 0.45% | 7,749,570 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Iovance Biotherapeutics (DE:2LB)?
According to the latest TipRanks data, approximately 35.62% of the company's stock is held by institutional investors, 9.64% is held by insiders, and 19.91% is held by retail investors.
What percentage of Iovance Biotherapeutics (DE:2LB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 35.62% of Iovance Biotherapeutics (DE:2LB) stock is held by institutional investors.
What percentage of Iovance Biotherapeutics (DE:2LB) stock is held by retail investors?
According to the latest TipRanks data, approximately 19.91% of Iovance Biotherapeutics (DE:2LB) stock is held by retail investors.
Who owns the most shares of Iovance Biotherapeutics (DE:2LB)?
Wayne P. Rothbaum owns the most shares of Iovance Biotherapeutics (DE:2LB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.